202 related articles for article (PubMed ID: 31852981)
1. A network pharmacology approach to reveal the protective mechanism of Salvia miltiorrhiza-Dalbergia odorifera coupled-herbs on coronary heart disease.
Li F; Duan J; Zhao M; Huang S; Mu F; Su J; Liu K; Pan Y; Lu X; Li J; Wei P; Xi M; Wen A
Sci Rep; 2019 Dec; 9(1):19343. PubMed ID: 31852981
[TBL] [Abstract][Full Text] [Related]
2. Network pharmacology and molecular docking reveal the effective substances and active mechanisms of Dalbergia Odoriferain protecting against ischemic stroke.
Liu K; Tao X; Su J; Li F; Mu F; Zhao S; Lu X; Li J; Chen S; Dong T; Duan J; Wei P; Xi M
PLoS One; 2021; 16(9):e0255736. PubMed ID: 34582494
[TBL] [Abstract][Full Text] [Related]
3. Metabonomic Strategy for the Evaluation of Chinese Medicine Salvia miltiorrhiza and Dalbergia odorifera Interfering with Myocardial Ischemia/Reperfusion Injury in Rats.
Mu F; Duan J; Bian H; Zhai X; Shang P; Lin R; Zhao M; Hu D; Yin Y; Wen A; Xi M
Rejuvenation Res; 2017 Aug; 20(4):263-277. PubMed ID: 28093038
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effects and underlying mechanism of Radix Salvia miltiorrhiza and Lignum Dalbergia odorifera in a pig chronic myocardial ischemia model.
Lin R; Duan J; Mu F; Bian H; Zhao M; Zhou M; Li Y; Wen A; Yang Y; Xi M
Int J Mol Med; 2018 Nov; 42(5):2628-2640. PubMed ID: 30226574
[TBL] [Abstract][Full Text] [Related]
5.
Lin R; Mu F; Li Y; Duan J; Zhao M; Guan Y; Liu K; Bai Y; Wen A; Wei P; Wang J; Xi M
Oxid Med Cell Longev; 2021; 2021():8840896. PubMed ID: 34007406
[No Abstract] [Full Text] [Related]
6. Multi-target pharmacological mechanisms of Salvia miltiorrhiza against oral submucous fibrosis: A network pharmacology approach.
Cai X; Zhang H; Li T
Arch Oral Biol; 2021 Jun; 126():105131. PubMed ID: 33894647
[TBL] [Abstract][Full Text] [Related]
7. A network pharmacology approach to investigate the anti-inflammatory mechanism of effective ingredients from Salvia miltiorrhiza.
Cui S; Chen S; Wu Q; Chen T; Li S
Int Immunopharmacol; 2020 Apr; 81():106040. PubMed ID: 31818704
[TBL] [Abstract][Full Text] [Related]
8. The Synergistic Effects of
Zhang Y; Wang J; Liu YM; Chen YY; Yang XC; Duan L
Drug Des Devel Ther; 2021; 15():4053-4069. PubMed ID: 34611395
[TBL] [Abstract][Full Text] [Related]
9. Co-administration of Dalbergia odorifera increased bioavailability of Salvia miltiorrhizae in rabbits.
Zheng X; Zhao X; Wang S; Luo K; Wei Y; Zheng J
Am J Chin Med; 2007; 35(5):831-40. PubMed ID: 17963322
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of tanshinones and phenolic acids from Danshen in the treatment of coronary heart disease based on co-expression network.
Wu D; Huo M; Chen X; Zhang Y; Qiao Y
BMC Complement Med Ther; 2020 Feb; 20(1):28. PubMed ID: 32020855
[TBL] [Abstract][Full Text] [Related]
11. Cardiac effects of salvia miltiorrhiza/dalbergia odorifera mixture, an intravenously applicable Chinese medicine widely used for patients with ischemic heart disease in China.
Sugiyama A; Zhu BM; Takahara A; Satoh Y; Hashimoto K
Circ J; 2002 Feb; 66(2):182-4. PubMed ID: 11999645
[TBL] [Abstract][Full Text] [Related]
12. Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network.
Mao X; Xu H; Li S; Su J; Li W; Guo Q; Wang P; Guo R; Xiao X; Zhang Y; Yang H
Phytomedicine; 2019 Feb; 54():159-168. PubMed ID: 30668365
[TBL] [Abstract][Full Text] [Related]
13. Using Coexpression Protein Interaction Network Analysis to Identify Mechanisms of Danshensu Affecting Patients with Coronary Heart Disease.
Huo M; Wang Z; Wu D; Zhang Y; Qiao Y
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629174
[No Abstract] [Full Text] [Related]
14. Pharmacodynamic substances in Salvia miltiorrhiza for prevention and treatment of hyperlipidemia and coronary heart disease based on lipidomics technology and network pharmacology analysis.
Sun G; Li X; Wei J; Zhang T; Li B; Chen M; Wang Y; Chen K; Li Y
Biomed Pharmacother; 2021 Sep; 141():111846. PubMed ID: 34225018
[TBL] [Abstract][Full Text] [Related]
15. Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases.
Wang L; Ma R; Liu C; Liu H; Zhu R; Guo S; Tang M; Li Y; Niu J; Fu M; Gao S; Zhang D
Curr Pharm Des; 2017; 23(7):1077-1097. PubMed ID: 27748194
[TBL] [Abstract][Full Text] [Related]
16. A critical courier role of volatile oils from Dalbergia odorifera for cardiac protection in vivo by QiShenYiQi.
Yu J; Zhang W; Zhang Y; Wang Y; Zhang B; Fan G; Zhu Y
Sci Rep; 2017 Aug; 7(1):7353. PubMed ID: 28779167
[TBL] [Abstract][Full Text] [Related]
17. Investigating the anti-atherosclerotic effects and potential mechanism of Dalbergia odorifera in ApoE-deficient mice using network pharmacology combined with metabolomics.
Sun K; Li Z; Li W; Chi C; Wang M; Xu R; Gao Y; Li B; Sun Y; Liu R
J Pharm Biomed Anal; 2024 May; 242():116017. PubMed ID: 38387125
[TBL] [Abstract][Full Text] [Related]
18. A Dalbergia odorifera extract improves the survival of endotoxemia model mice by inhibiting HMGB1 release.
Choi HS; Park JA; Hwang JS; Ham SA; Yoo T; Lee WJ; Paek KS; Shin HC; Lee CH; Seo HG
BMC Complement Altern Med; 2017 Apr; 17(1):212. PubMed ID: 28403838
[TBL] [Abstract][Full Text] [Related]
19. Based on Serum Pharmacochemistry and Virtual Screening Technique Analysis Used to Explore the Potential Active Ingredients and Possible Anti- Coronary Heart Disease Mechanisms of Salvia miltiorrhiza Bunge.
Shi Y; Li Q; Zhu J; Hou CW; Li XL; Liu XD; Tong QZ
Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38204249
[TBL] [Abstract][Full Text] [Related]
20. Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation.
Qin T; Wu L; Hua Q; Song Z; Pan Y; Liu T
J Ethnopharmacol; 2020 Jan; 246():112128. PubMed ID: 31386888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
